Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T02702 | Target Info | |||
Target Name | Bacterial Dihydrofolate reductase (Bact DHFR) | ||||
Synonyms | Bact Dihydrofolate reductase | ||||
Target Type | Clinical trial Target | ||||
Gene Name | Bact DHFR | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Folic acid | Ligand Info | |||||
Structure Description | Cryogenic WT DHFR | PDB:4KJJ | ||||
Method | X-ray diffraction | Resolution | 1.15 Å | Mutation | No | [1] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
|
ILE5
1.855
ALA6
2.709
ALA7
2.405
MET20
2.590
TRP22
3.992
PRO25
4.529
ASP27
1.977
LEU28
2.004
ALA29
2.740
TRP30
2.851
PHE31
2.458
LYS32
2.122
THR35
4.768
LEU36
4.994
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: Methotrexate | Ligand Info | |||||
Structure Description | Crystal structure of the ternary MTX NADPH complex of Escherichia coli dihydrofolate reductase | PDB:3DAU | ||||
Method | X-ray diffraction | Resolution | 1.50 Å | Mutation | No | [2] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
|
ILE5
2.818
ALA6
3.422
ALA7
3.773
MET20
2.890
PRO25
3.409
ASP27
2.659
LEU28
3.449
ALA29
3.530
TRP30
4.141
PHE31
3.416
LYS32
3.324
THR35
4.875
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: Levoleucovorin | Ligand Info | |||||
Structure Description | THE CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN FOLINIC ACID (LEUCOVORIN) AND E. COLI DIHYDROFOLATE REDUCTASE | PDB:1JOM | ||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [3] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .FFO or .FFO2 or .FFO3 or :3FFO;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:15 or .A:16 or .A:17 or .A:20 or .A:22 or .A:27 or .A:28 or .A:30 or .A:31 or .A:32 or .A:35 or .A:50 or .A:54 or .A:55 or .A:57 or .A:94 or .A:100 or .A:113; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: Urea | Ligand Info | |||||
Structure Description | MOLECULE: DIHYDROFOLATE REDUCTASE (E.C.1.5.1.3) COMPLEXED WITH METHOTREXATE AND UREA | PDB:1DDR | ||||
Method | X-ray diffraction | Resolution | 2.45 Å | Mutation | No | [4] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .URE or .URE2 or .URE3 or :3URE;style chemicals stick;color identity;select .A:44 or .A:45 or .A:52 or .A:62 or .A:63 or .A:64 or .A:65 or .A:76 or .A:77 or .A:102; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: Arginine | Ligand Info | |||||
Structure Description | Crystal structure of Escherichia coli dihydrofolate reductase in complex with TRIMETHOPRIM and NADPH | PDB:7MYM | ||||
Method | X-ray diffraction | Resolution | 3.04 Å | Mutation | No | [5] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILER |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .ARG or .ARG2 or .ARG3 or :3ARG;style chemicals stick;color identity;select .A:130 or .A:131 or .A:132 or .A:133 or .A:134 or .A:157 or .A:158; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: Trimethoprim | Ligand Info | |||||
Structure Description | Crystal structure of GFP-LAMA-G97 - a GFP enhancer nanobody with cpDHFR insertion and TMP and NADPH | PDB:6RUM | ||||
Method | X-ray diffraction | Resolution | 1.60 Å | Mutation | No | [6] |
PDB Sequence |
QVQLVESGGA
10 LVQPGGSLRL20 SCAASGFPVN30 RYSMRWYRQA40 PGKEREWVAG50 MSSAGDRSSY 59 EDSVKGRFTI69 SRDDARNTVY79 LQMNSLKPED86 TAVYYCNVNV96 GLPADLAWFK 106 RNTLNKPVIM116 GRHTWESIGR126 PLPGRKNIIL136 SSQPGTDDRV146 TWVKSVDEAI 156 AACGDVPEIM166 VIGGGRVYEQ176 FLPKAQKLYL186 THIDAEVEGD196 THFPDYEPDD 206 WESVFSEFHD216 ADAQNSHSYC226 FEILERRGGG238 MISLIAALAV248 DRVIGMENAM 258 PWNFEYWGQG268 TQVTVS
|
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .TOP or .TOP2 or .TOP3 or :3TOP;style chemicals stick;color identity;select .A:95 or .A:101 or .A:102 or .A:104 or .A:105 or .A:120 or .A:123 or .A:124 or .A:126 or .A:128 or .A:167 or .A:168 or .A:169 or .A:174 or .A:187 or .A:243 or .A:244 or .A:245 or .A:258 or .A:261; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ASN95
3.788
ASP101
2.796
LEU102
4.068
TRP104
4.331
PHE105
3.343
THR120
4.968
SER123
3.553
ILE124
3.731
ARG126
4.001
LEU128
4.133
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: NADP+ | Ligand Info | |||||
Structure Description | Cryogenic WT DHFR | PDB:4KJJ | ||||
Method | X-ray diffraction | Resolution | 1.15 Å | Mutation | No | [1] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NAP or .NAP2 or .NAP3 or :3NAP;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:8 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:20 or .A:22 or .A:42 or .A:43 or .A:44 or .A:45 or .A:46 or .A:47 or .A:49 or .A:50 or .A:62 or .A:63 or .A:64 or .A:65 or .A:75 or .A:76 or .A:77 or .A:78 or .A:94 or .A:95 or .A:96 or .A:97 or .A:98 or .A:99 or .A:100 or .A:102 or .A:115 or .A:122 or .A:123; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE5
4.438
ALA6
2.548
ALA7
1.830
LEU8
4.185
ILE14
2.027
GLY15
2.406
MET16
3.411
GLU17
4.111
ASN18
1.834
ALA19
2.847
MET20
2.389
TRP22
2.200
MET42
4.925
GLY43
2.574
ARG44
1.647
HIS45
1.856
THR46
1.771
TRP47
4.756
SER49
2.474
ILE50
4.851
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: NADPH | Ligand Info | |||||
Structure Description | L28F E.coli DHFR in complex with NADPH | PDB:5W3Q | ||||
Method | X-ray diffraction | Resolution | 1.40 Å | Mutation | Yes | [7] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADFAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .NDP or .NDP2 or .NDP3 or :3NDP;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:8 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:20 or .A:21 or .A:22 or .A:43 or .A:44 or .A:45 or .A:46 or .A:47 or .A:49 or .A:62 or .A:63 or .A:64 or .A:65 or .A:75 or .A:76 or .A:77 or .A:78 or .A:94 or .A:95 or .A:96 or .A:97 or .A:98 or .A:99 or .A:100 or .A:102 or .A:122 or .A:123; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE5
4.220
ALA6
2.686
ALA7
1.966
LEU8
4.126
VAL13
4.901
ILE14
1.970
GLY15
2.378
MET16
3.499
GLU17
4.079
ASN18
2.094
ALA19
2.973
MET20
2.538
PRO21
4.868
TRP22
2.471
GLY43
2.625
ARG44
1.867
HIS45
2.195
THR46
1.940
TRP47
4.797
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: 3-Sulfinoalanine | Ligand Info | |||||
Structure Description | E. coli DHFR by Native Mn,P,S-SAD at Room Temperature | PDB:7LVC | ||||
Method | X-ray diffraction | Resolution | 1.70 Å | Mutation | No | [8] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .CSD or .CSD2 or .CSD3 or :3CSD;style chemicals stick;color identity;select .A:112 or .A:113 or .A:114 or .A:115 or .A:138 or .A:139 or .A:140 or .A:141 or .A:150 or .A:151 or .A:153 or .A:154; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: 2'-Monophosphoadenosine-5'-Diphosphate | Ligand Info | |||||
Structure Description | DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE AND 2-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE | PDB:1RA8 | ||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [9] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .ATR or .ATR2 or .ATR3 or :3ATR;style chemicals stick;color identity;select .A:43 or .A:44 or .A:45 or .A:46 or .A:62 or .A:63 or .A:64 or .A:65 or .A:75 or .A:76 or .A:77 or .A:78 or .A:95 or .A:96 or .A:97 or .A:98 or .A:99 or .A:102 or .A:123; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: Tellurium | Ligand Info | |||||
Structure Description | EXPRESSION, CHARACTERIZATION, AND CRYSTALLOGRAPHIC ANALYSIS OF TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE | PDB:1TDR | ||||
Method | X-ray diffraction | Resolution | 2.50 Å | Mutation | No | [10] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFKILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .TE or .TE2 or .TE3 or :3TE;style chemicals stick;color identity;select .A:3 or .A:34 or .A:38 or .A:42 or .A:43 or .A:46 or .A:47 or .A:50 or .A:61 or .A:90 or .A:91 or .A:92 or .A:94 or .A:111; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: S,S-(2-Hydroxyethyl)Thiocysteine | Ligand Info | |||||
Structure Description | High-pressure Crystal Structure Analysis of DHFR(0.1 MPa) | PDB:5Z6F | ||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [11] |
PDB Sequence |
HMISLIAALA
9 VDRVIGMENA19 MPWNLPADLA29 WFKRNTLNKP39 VIMGRHTWES49 IGRPLPGRKN 59 IILSSQPGTD69 DRVTWVKSVD79 EAIAACGDVP89 EIMVIGGGRV99 YEQFLPKAQK 109 LYLTHIDAEV119 EGDTHFPDYE129 PDDWESVFSE139 FHDADAQNSH149 SYFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .CME or .CME2 or .CME3 or :3CME;style chemicals stick;color identity;select .A:112 or .A:113 or .A:114 or .A:138 or .A:139 or .A:140 or .A:141 or .A:150 or .A:151 or .A:153 or .A:154; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: (6s)-5,6,7,8-Tetrahydrofolate | Ligand Info | |||||
Structure Description | E. coli DHFR complex with a reaction intermediate | PDB:6MR9 | ||||
Method | X-ray diffraction | Resolution | 1.35 Å | Mutation | No | [12] |
PDB Sequence |
MISLIAALAV
10 DRVIGMMPWN23 LPADLAWFKR33 NTLNKPVIMG43 RHTWESIGRP53 LPGRKNIILS 63 SQPGTDDRVT73 WVKSVDEAIA83 ACGDVPEIMV93 IGGGRVYEQF103 LPKAQKLYLT 113 HIDAEVEGDT123 HFPDYEPDDW133 ESVFSEFHDA143 DAQNSHSYCF153 EILERRHHH |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .THG or .THG2 or .THG3 or :3THG;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:15 or .A:16 or .A:20 or .A:22 or .A:27 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:35 or .A:46 or .A:50 or .A:54 or .A:55 or .A:57 or .A:94 or .A:95 or .A:100 or .A:111 or .A:112 or .A:113 or .A:153; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE5
2.323
ALA6
2.617
ALA7
2.679
GLY15
3.849
MET16
2.954
MET20
3.658
TRP22
4.194
ASP27
1.776
LEU28
2.168
ALA29
4.667
TRP30
2.563
PHE31
2.583
LYS32
2.744
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: Dihydrofolic acid | Ligand Info | |||||
Structure Description | E. coli DHFR complex modeled with two ligand states | PDB:6MT8 | ||||
Method | X-ray diffraction | Resolution | 1.35 Å | Mutation | No | [12] |
PDB Sequence |
MISLIAALAV
10 DRVIGMMPWN23 LPADLAWFKR33 NTLNKPVIMG43 RHTWESIGRP53 LPGRKNIILS 63 SQPGTDDRVT73 WVKSVDEAIA83 ACGDVPEIMV93 IGGGRVYEQF103 LPKAQKLYLT 113 HIDAEVEGDT123 HFPDYEPDDW133 ESVFSEFHDA143 DAQNSHSYCF153 EILERRHHH |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .DHF or .DHF2 or .DHF3 or :3DHF;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:15 or .A:16 or .A:20 or .A:22 or .A:25 or .A:27 or .A:28 or .A:30 or .A:31 or .A:32 or .A:35 or .A:46 or .A:49 or .A:50 or .A:54 or .A:55 or .A:57 or .A:94 or .A:95 or .A:100 or .A:111 or .A:112 or .A:113 or .A:153; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE5
2.063
ALA6
2.811
ALA7
2.597
GLY15
4.002
MET16
2.445
MET20
4.142
TRP22
4.203
PRO25
4.885
ASP27
2.125
LEU28
2.410
TRP30
2.577
PHE31
2.523
LYS32
2.847
THR35
4.354
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: Phenformin | Ligand Info | |||||
Structure Description | structure of DHFR with bound phenformin and NADP | PDB:5UIH | ||||
Method | X-ray diffraction | Resolution | 1.65 Å | Mutation | No | [13] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .8CV or .8CV2 or .8CV3 or :38CV;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:15 or .A:16 or .A:22 or .A:27 or .A:28 or .A:30 or .A:31 or .A:50 or .A:54 or .A:94 or .A:95 or .A:100 or .A:113; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: 5,10-Dideazatetrahydrofolic acid | Ligand Info | |||||
Structure Description | L28F E.coli dihydrofolate reductase complexed with 5,10-dideazatetrahydrofolate and oxidized nicotinamide adenine dinucleotide phosphate | PDB:5CC9 | ||||
Method | X-ray diffraction | Resolution | 1.20 Å | Mutation | Yes | [14] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADFAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .DDF or .DDF2 or .DDF3 or :3DDF;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:15 or .A:20 or .A:22 or .A:27 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:35 or .A:36 or .A:46 or .A:50 or .A:54 or .A:55 or .A:57 or .A:94 or .A:95 or .A:100 or .A:111 or .A:113 or .A:153; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE5
1.902
ALA6
2.604
ALA7
2.604
GLY15
4.415
MET20
4.820
TRP22
3.666
ASP27
2.017
PHE28
2.083
ALA29
4.666
TRP30
2.596
PHE31
2.562
LYS32
2.536
THR35
4.417
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: Deuterium Oxide | Ligand Info | |||||
Structure Description | Neutron crystal Structure of E.coli Dihydrofolate Reductase complexed with folate and NADP+ | PDB:4PDJ | ||||
Method | X-ray diffraction | Resolution | 1.60 Å | Mutation | No | [15] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .DOD or .DOD2 or .DOD3 or :3DOD;style chemicals stick;color identity;select .A:1 or .A:2 or .A:3 or .A:5 or .A:6 or .A:7 or .A:8 or .A:9 or .A:10 or .A:11 or .A:12 or .A:13 or .A:14 or .A:15 or .A:16 or .A:17 or .A:18 or .A:19 or .A:20 or .A:21 or .A:22 or .A:23 or .A:24 or .A:25 or .A:26 or .A:27 or .A:28 or .A:29 or .A:30 or .A:32 or .A:33 or .A:34 or .A:35 or .A:36 or .A:37 or .A:38 or .A:39 or .A:44 or .A:45 or .A:46 or .A:47 or .A:48 or .A:49 or .A:50 or .A:51 or .A:52 or .A:53 or .A:54 or .A:55 or .A:56 or .A:57 or .A:58 or .A:59 or .A:61 or .A:62 or .A:63 or .A:64 or .A:65 or .A:66 or .A:67 or .A:68 or .A:69 or .A:70 or .A:71 or .A:72 or .A:73 or .A:74 or .A:75 or .A:76 or .A:77 or .A:78 or .A:79 or .A:80 or .A:82 or .A:83 or .A:84 or .A:85 or .A:86 or .A:87 or .A:88 or .A:89 or .A:90 or .A:91 or .A:92 or .A:97 or .A:98 or .A:100 or .A:101 or .A:102 or .A:103 or .A:104 or .A:105 or .A:106 or .A:107 or .A:108 or .A:109 or .A:111 or .A:112 or .A:113 or .A:114 or .A:115 or .A:116 or .A:117 or .A:118 or .A:119 or .A:120 or .A:121 or .A:122 or .A:123 or .A:124 or .A:125 or .A:126 or .A:127 or .A:128 or .A:129 or .A:130 or .A:131 or .A:132 or .A:133 or .A:134 or .A:135 or .A:136 or .A:138 or .A:139 or .A:140 or .A:141 or .A:142 or .A:143 or .A:144 or .A:145 or .A:146 or .A:147 or .A:148 or .A:149 or .A:150 or .A:151 or .A:152 or .A:153 or .A:154 or .A:156 or .A:157 or .A:158 or .A:159; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
MET1
1.961
ILE2
1.889
SER3
4.776
ILE5
2.429
ALA6
2.660
ALA7
3.616
LEU8
3.078
ALA9
2.388
VAL10
2.173
ASP11
1.951
ARG12
1.979
VAL13
2.357
ILE14
4.816
GLY15
3.931
MET16
2.817
GLU17
2.626
ASN18
1.788
ALA19
2.854
MET20
1.870
PRO21
4.799
TRP22
1.828
ASN23
1.795
LEU24
1.751
PRO25
2.042
ALA26
2.108
ASP27
1.663
LEU28
2.512
ALA29
2.323
TRP30
1.993
LYS32
2.090
ARG33
1.647
ASN34
1.966
THR35
3.575
LEU36
2.083
ASN37
2.637
LYS38
1.886
PRO39
2.519
ARG44
2.566
HIS45
2.706
THR46
3.473
TRP47
1.876
GLU48
1.931
SER49
1.853
ILE50
3.122
GLY51
2.147
ARG52
2.721
PRO53
2.508
LEU54
2.770
PRO55
2.611
GLY56
1.956
ARG57
2.516
LYS58
2.550
ASN59
1.828
ILE61
4.298
LEU62
4.421
SER63
2.328
SER64
2.847
GLN65
2.020
PRO66
2.056
GLY67
1.812
THR68
2.247
ASP69
1.881
ASP70
1.901
ARG71
1.879
VAL72
2.096
THR73
1.906
TRP74
1.989
VAL75
2.318
LYS76
2.303
SER77
1.775
VAL78
2.772
ASP79
2.008
GLU80
1.928
ILE82
1.800
ALA83
2.690
ALA84
4.874
CYS85
2.597
GLY86
2.058
ASP87
2.953
VAL88
1.970
PRO89
2.400
GLU90
2.037
ILE91
2.789
MET92
4.657
GLY97
2.999
ARG98
1.717
TYR100
4.031
GLU101
2.120
GLN102
2.026
PHE103
4.132
LEU104
2.527
PRO105
2.200
LYS106
2.353
ALA107
3.078
GLN108
1.747
LYS109
1.847
TYR111
2.084
LEU112
2.827
THR113
2.158
HIS114
1.658
ILE115
2.356
ASP116
1.549
ALA117
3.824
GLU118
2.297
VAL119
1.785
GLU120
1.979
GLY121
4.790
ASP122
1.984
THR123
2.318
HIS124
1.949
PHE125
2.974
PRO126
2.304
ASP127
4.830
TYR128
2.239
GLU129
1.758
PRO130
2.053
ASP131
2.031
ASP132
2.794
TRP133
2.071
GLU134
2.746
SER135
1.873
VAL136
3.112
SER138
1.741
GLU139
3.039
PHE140
1.984
HIS141
1.742
ASP142
1.954
ALA143
1.887
ASP144
2.304
ALA145
4.040
GLN146
2.140
ASN147
2.732
SER148
2.040
HIS149
2.420
SER150
1.926
TYR151
1.902
CYS152
2.806
PHE153
2.951
GLU154
2.005
LEU156
2.904
GLU157
1.579
ARG158
2.218
ARG159
2.233
|
|||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: (2s,2's)-5,5'-(Nonane-1,9-Diyldiimino)bis(2-{[(4-{[(2,4-Diaminopteridin-6-Yl)methyl](Methyl)amino}phenyl)carbonyl]amino}-5-Oxopentanoic Acid) (Non-Preferred Name) | Ligand Info | |||||
Structure Description | Chemically Self-assembled Antibody Nanorings (CSANs): Design and Characterization of an Anti-CD3 IgM Biomimetic | PDB:3OCH | ||||
Method | X-ray diffraction | Resolution | 1.79 Å | Mutation | No | [16] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .2MX or .2MX2 or .2MX3 or :32MX;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:27 or .A:28 or .A:30 or .A:31 or .A:32 or .A:35 or .A:46 or .A:49 or .A:50 or .A:52 or .A:54 or .A:55 or .A:57 or .A:94 or .A:95 or .A:100 or .A:113; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: (7s)-7-Methyl-5,6,7,8-Tetrahydroquinazoline-2,4-Diamine | Ligand Info | |||||
Structure Description | Sensitivity of receptor internal motions to ligand binding affinity and kinetic off-rate | PDB:3QYL | ||||
Method | X-ray diffraction | Resolution | 1.79 Å | Mutation | No | [17] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .7ME or .7ME2 or .7ME3 or :37ME;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:20 or .A:27 or .A:28 or .A:30 or .A:31 or .A:50 or .A:94 or .A:95 or .A:100 or .A:113; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: 5-Deazafolic acid | Ligand Info | |||||
Structure Description | ISOMORPHOUS CRYSTAL STRUCTURES OF ESCHERICHIA COLI DIHYDROFOLATE REDUCTASE COMPLEXED WITH FOLATE, 5-DEAZAFOLATE AND 5,10-DIDEAZATETRAHYDROFOLATE: MECHANISTIC IMPLICATIONS | PDB:1DYH | ||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | No | [18] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .DZF or .DZF2 or .DZF3 or :3DZF;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:27 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:35 or .A:46 or .A:49 or .A:50 or .A:52 or .A:54 or .A:55 or .A:57 or .A:94 or .A:100 or .A:113; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: 5-[(4-Chlorophenyl)sulfanyl]quinazoline-2,4-Diamine | Ligand Info | |||||
Structure Description | Dynamic switching and partial occupancies of a small molecule inhibitor complex of DHFR | PDB:3KFY | ||||
Method | X-ray diffraction | Resolution | 2.08 Å | Mutation | Yes | [19] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .JZM or .JZM2 or .JZM3 or :3JZM;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:14 or .A:20 or .A:27 or .A:28 or .A:30 or .A:31 or .A:46 or .A:94 or .A:95 or .A:96 or .A:97 or .A:100 or .A:113; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: (6s)-6-Methyl-5,6,7,8-Tetrahydroquinazoline-2,4-Diamine | Ligand Info | |||||
Structure Description | Evidence for dynamic motion in proteins as a mechanism for ligand dissociation | PDB:3R33 | ||||
Method | X-ray diffraction | Resolution | 2.09 Å | Mutation | No | [17] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .6ME or .6ME2 or .6ME3 or :36ME;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:20 or .A:27 or .A:28 or .A:30 or .A:31 or .A:46 or .A:50 or .A:94 or .A:95 or .A:100 or .A:113; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: Quinazoline-2,4-diamine | Ligand Info | |||||
Structure Description | Sensitivity of receptor internal motions to ligand binding affinity and kinetic off-rate | PDB:3QYO | ||||
Method | X-ray diffraction | Resolution | 2.09 Å | Mutation | No | [17] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .Q24 or .Q242 or .Q243 or :3Q24;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:20 or .A:27 or .A:28 or .A:30 or .A:31 or .A:50 or .A:94 or .A:95 or .A:100 or .A:113; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: (2,5-Dimethylbenzene-1,4-Diyl)dimethanediyl Bis(N-Carbamimidoylcarbamimidothioate) | Ligand Info | |||||
Structure Description | Crystal Structure of E.coli DHFR in complex with NADPH and the inhibitor compound 10a. | PDB:2ANQ | ||||
Method | X-ray diffraction | Resolution | 2.13 Å | Mutation | Yes | [20] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .C1A or .C1A2 or .C1A3 or :3C1A;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:18 or .A:19 or .A:20 or .A:27 or .A:28 or .A:30 or .A:31 or .A:46 or .A:49 or .A:50 or .A:94 or .A:95 or .A:100 or .A:113; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: N-(4-{[(2,4-Diaminopteridin-1-Ium-6-Yl)methyl](Methyl)amino}benzoyl)-L-Glutamic Acid | Ligand Info | |||||
Structure Description | Neutron Crystal Structure of Escherichia coli Dihydrofolate Reductase Bound to the Anti-cancer drug, Methotrexate | PDB:2INQ | ||||
Method | Neutron diffraction | Resolution | 2.20 Å | Mutation | Yes | [21] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .MT1 or .MT12 or .MT13 or :3MT1;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:27 or .A:28 or .A:29 or .A:30 or .A:31 or .A:32 or .A:35 or .A:46 or .A:49 or .A:50 or .A:52 or .A:54 or .A:55 or .A:57 or .A:93 or .A:94 or .A:95 or .A:100 or .A:111 or .A:112 or .A:113 or .A:153; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE5
1.475
ALA6
2.207
ALA7
2.799
ASP27
1.757
LEU28
2.432
ALA29
4.310
TRP30
3.185
PHE31
2.343
LYS32
2.920
THR35
4.647
THR46
2.232
SER49
2.606
ILE50
2.609
|
|||||
Ligand Name: 1-{[N-(1-Imino-guanidino-methyl)]sulfanylmethyl}-3-trifluoromethyl-benzene | Ligand Info | |||||
Structure Description | Crystal structure of E.coli dihydrofolate reductase in complex with NADPH and the inhibitor MS-SH08-17 | PDB:2ANO | ||||
Method | X-ray diffraction | Resolution | 2.68 Å | Mutation | Yes | [20] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLDKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .817 or .8172 or .8173 or :3817;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:20 or .A:27 or .A:28 or .A:30 or .A:31 or .A:46 or .A:50 or .A:54 or .A:94 or .A:100 or .A:113; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: Buformin | Ligand Info | |||||
Structure Description | structure of DHFR with bound buformin and NADP | PDB:5UII | ||||
Method | X-ray diffraction | Resolution | 1.35 Å | Mutation | Yes | [13] |
PDB Sequence |
GISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YSFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .BFR or .BFR2 or .BFR3 or :3BFR;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:27 or .A:28 or .A:30 or .A:31 or .A:46 or .A:49 or .A:50 or .A:54 or .A:93 or .A:94 or .A:95 or .A:100 or .A:111 or .A:113 or .A:153; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Ligand Name: 2,4-Diaminopyrimidine | Ligand Info | |||||
Structure Description | structure of DHFR with bound DAP, p-ABG and NADP | PDB:5UIP | ||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | Yes | [13] |
PDB Sequence |
GISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YSFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .LG3 or .LG32 or .LG33 or :3LG3;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:27 or .A:28 or .A:30 or .A:31 or .A:94 or .A:100 or .A:113; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: N-(4-Aminobenzoyl)-L-glutamic acid | Ligand Info | |||||
Structure Description | structure of DHFR with bound DAP, p-ABG and NADP | PDB:5UIP | ||||
Method | X-ray diffraction | Resolution | 1.90 Å | Mutation | Yes | [13] |
PDB Sequence |
GISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YSFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .8DM or .8DM2 or .8DM3 or :38DM;style chemicals stick;color identity;select .A:28 or .A:31 or .A:32 or .A:35 or .A:46 or .A:50 or .A:52 or .A:54 or .A:55 or .A:57; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
||||||
Click to View More Binding Site Information of This Target and Ligand Pair | ||||||
Ligand Name: 7-[(3-aminophenyl)methyl]-7H-pyrrolo[3,2-f]quinazoline-1,3-diamine | Ligand Info | |||||
Structure Description | E. coli DHFR complex with inhibitor AMPQD | PDB:6CQA | ||||
Method | X-ray diffraction | Resolution | 2.20 Å | Mutation | No | [22] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .PQD or .PQD2 or .PQD3 or :3PQD;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:16 or .A:18 or .A:22 or .A:27 or .A:28 or .A:30 or .A:31 or .A:32 or .A:46 or .A:49 or .A:50 or .A:52 or .A:54 or .A:93 or .A:94 or .A:95 or .A:100 or .A:111 or .A:112 or .A:113 or .A:153; color #f3c393; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
ILE5
2.115
ALA6
2.759
ALA7
2.790
MET16
3.497
ASN18
3.197
TRP22
3.876
ASP27
1.987
LEU28
3.115
TRP30
3.137
PHE31
2.546
LYS32
3.258
THR46
2.357
|
|||||
Ligand Name: 7-[(2-Fluorophenyl)methyl]pyrrolo[3,2-f]quinazoline-1,3-diamine | Ligand Info | |||||
Structure Description | cocrystallization of Escherichia coli dihydrofolate reductase (DHFR) and its pyrrolo[3,2-f]quinazoline inhibitor. | PDB:7F3B | ||||
Method | X-ray diffraction | Resolution | 2.81 Å | Mutation | No | [23] |
PDB Sequence |
MISLIAALAV
10 DRVIGMENAM20 PWNLPADLAW30 FKRNTLNKPV40 IMGRHTWESI50 GRPLPGRKNI 60 ILSSQPGTDD70 RVTWVKSVDE80 AIAACGDVPE90 IMVIGGGRVY100 EQFLPKAQKL 110 YLTHIDAEVE120 GDTHFPDYEP130 DDWESVFSEF140 HDADAQNSHS150 YCFEILERR |
|||||
Click to Show 3D Structure of This Binding Site
set background white;style ions nothing; color 8e8e8e;style chemicals nothing; select .D4C or .D4C2 or .D4C3 or :3D4C;style chemicals stick;color identity;select .A:5 or .A:6 or .A:7 or .A:17 or .A:18 or .A:22 or .A:27 or .A:28 or .A:30 or .A:31 or .A:32 or .A:46 or .A:49 or .A:50 or .A:54 or .A:94 or .A:95 or .A:100 or .A:111 or .A:113; color #00ffc7; zoom selection;set surface opacity 0.5;set surface Van der Waals surface;set mode all
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Automated identification of functional dynamic contact networks from X-ray crystallography. Nat Methods. 2013 Sep;10(9):896-902. | ||||
REF 2 | X-ray structure of the ternary MTX.NADPH complex of the anthrax dihydrofolate reductase: a pharmacophore for dual-site inhibitor design. J Struct Biol. 2009 May;166(2):162-71. | ||||
REF 3 | Crystal structures of Escherichia coli dihydrofolate reductase complexed with 5-formyltetrahydrofolate (folinic acid) in two space groups: evidence for enolization of pteridine O4. Biochemistry. 1996 Jun 4;35(22):7012-20. | ||||
REF 4 | The effect of denaturants on protein structure. Protein Sci. 1997 Aug;6(8):1727-33. | ||||
REF 5 | Structure-guided functional studies of plasmid-encoded dihydrofolate reductases reveal a common mechanism of trimethoprim resistance in Gram-negative pathogens. Commun Biol. 2022 May 13;5(1):459. | ||||
REF 6 | Chemogenetic Control of Nanobodies. Nat Methods. 2020 Mar;17(3):279-282. | ||||
REF 7 | Defining the Structural Basis for Allosteric Product Release from E. coli Dihydrofolate Reductase Using NMR Relaxation Dispersion. J Am Chem Soc. 2017 Aug 16;139(32):11233-11240. | ||||
REF 8 | Native SAD phasing at room temperature. Acta Crystallogr D Struct Biol. 2022 Aug 1;78(Pt 8):986-996. | ||||
REF 9 | Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. Biochemistry. 1997 Jan 21;36(3):586-603. | ||||
REF 10 | Expression, characterization and crystallographic analysis of telluromethionyl dihydrofolate reductase. Acta Crystallogr D Biol Crystallogr. 1995 Sep 1;51(Pt 5):731-9. | ||||
REF 11 | High-pressure protein crystal structure analysis of Escherichia coli dihydrofolate reductase complexed with folate and NADP(). Acta Crystallogr D Struct Biol. 2018 Sep 1;74(Pt 9):895-905. | ||||
REF 12 | Time-resolved x-ray crystallography capture of a slow reaction tetrahydrofolate intermediate. Struct Dyn. 2019 Mar 1;6(2):024701. | ||||
REF 13 | A Structural Basis for Biguanide Activity. Biochemistry. 2017 Sep 12;56(36):4786-4798. | ||||
REF 14 | Cofactor-Mediated Conformational Dynamics Promote Product Release From Escherichia coli Dihydrofolate Reductase via an Allosteric Pathway. J Am Chem Soc. 2015 Jul 29;137(29):9459-68. | ||||
REF 15 | Toward resolving the catalytic mechanism of dihydrofolate reductase using neutron and ultrahigh-resolution X-ray crystallography. Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18225-30. | ||||
REF 16 | Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic. J Am Chem Soc. 2010 Dec 8;132(48):17247-57. | ||||
REF 17 | Evidence for dynamics in proteins as a mechanism for ligand dissociation. Nat Chem Biol. 2012 Jan 15;8(3):246-52. | ||||
REF 18 | Isomorphous crystal structures of Escherichia coli dihydrofolate reductase complexed with folate, 5-deazafolate, and 5,10-dideazatetrahydrofolate: mechanistic implications. Biochemistry. 1995 Feb 28;34(8):2710-23. | ||||
REF 19 | Dynamic switching and partial occupancies of a small molecule inhibitor complex of DHFR | ||||
REF 20 | A 2.13 A structure of E. coli dihydrofolate reductase bound to a novel competitive inhibitor reveals a new binding surface involving the M20 loop region. J Med Chem. 2006 Nov 30;49(24):6977-86. | ||||
REF 21 | Neutron diffraction studies of Escherichia coli dihydrofolate reductase complexed with methotrexate. Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18493-8. | ||||
REF 22 | The crystal structure of a tetrahydrofolate-bound dihydrofolate reductase reveals the origin of slow product release. Commun Biol. 2018 Dec 12;1:226. | ||||
REF 23 | The discovery of 1, 3-diamino-7H-pyrrol[3, 2-f]quinazoline compounds as potent antimicrobial antifolates. Eur J Med Chem. 2022 Jan 15;228:113979. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.